Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26128 | 262 | 27.1 | 48% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
142 | 3 | DNA REPAIR//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//RADIATION RESEARCH | 64602 |
2147 | 2 | MGMT//O 6 METHYLGUANINE DNA METHYLTRANSFERASE//O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 5031 |
26128 | 1 | CLORETAZINE//VNP40101M//NEW ANTICANCER AGENT | 262 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CLORETAZINE | authKW | 971221 | 4% | 83% | 10 |
2 | VNP40101M | authKW | 932376 | 3% | 100% | 8 |
3 | NEW ANTICANCER AGENT | authKW | 407907 | 3% | 50% | 7 |
4 | SULFONYL HYDRAZONE | authKW | 381421 | 2% | 55% | 6 |
5 | DIPHOSPHINE DISULFIDE | authKW | 372949 | 2% | 80% | 4 |
6 | 1 2 BISSULFONYLHYDRAZINES | authKW | 349641 | 1% | 100% | 3 |
7 | ONRIGIN TM | authKW | 349641 | 1% | 100% | 3 |
8 | SELECTIVE LIQUID SOLID EXTRACTION | authKW | 349641 | 1% | 100% | 3 |
9 | SULFONYLHYDRAZINE PRODRUGS | authKW | 349641 | 1% | 100% | 3 |
10 | BISSULFONYLHYDRAZINES | authKW | 233094 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Inorganic & Nuclear | 902 | 21% | 0% | 56 |
2 | Chemistry, Medicinal | 520 | 14% | 0% | 36 |
3 | Spectroscopy | 361 | 11% | 0% | 28 |
4 | Oncology | 201 | 16% | 0% | 42 |
5 | Chemistry, Organic | 109 | 11% | 0% | 28 |
6 | Pharmacology & Pharmacy | 62 | 11% | 0% | 30 |
7 | Biochemical Research Methods | 46 | 5% | 0% | 14 |
8 | Crystallography | 36 | 4% | 0% | 10 |
9 | Chemistry, Analytical | 25 | 6% | 0% | 15 |
10 | Chemistry, Multidisciplinary | 23 | 9% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTICANC DRUG DEV CHEMOTHER Y | 174817 | 1% | 50% | 3 |
2 | USC INRA OENOL 1366 | 155395 | 1% | 67% | 2 |
3 | BIOCHEM MOL BIOL INFECT DIS | 116547 | 0% | 100% | 1 |
4 | ECOL INGN TRAVAUX AGR BORDEUX | 116547 | 0% | 100% | 1 |
5 | BLOOD MARROW TRANSPLANT GRP | 58272 | 0% | 50% | 1 |
6 | COMMUNITY BERGAMA | 58272 | 0% | 50% | 1 |
7 | DESIGN SYNTH BIOACT SUBST L ESSB | 38848 | 0% | 33% | 1 |
8 | PHARMACOL DEV THER EUT PROGRAM | 38848 | 0% | 33% | 1 |
9 | EA OENOL 4577 | 33831 | 1% | 10% | 3 |
10 | DEV THER EUT PROGRAM | 27142 | 6% | 1% | 16 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL CHEMISTRY | 3129 | 3% | 0% | 8 |
2 | SYNTHESIS AND REACTIVITY IN INORGANIC AND METAL-ORGANIC CHEMISTRY | 2761 | 3% | 0% | 8 |
3 | ORGANIC MASS SPECTROMETRY | 2734 | 3% | 0% | 7 |
4 | NEOPLASMA | 1834 | 3% | 0% | 7 |
5 | TRANSITION METAL CHEMISTRY | 1477 | 3% | 0% | 8 |
6 | JOURNAL OF MOLECULAR STRUCTURE | 1288 | 6% | 0% | 15 |
7 | JOURNAL OF COORDINATION CHEMISTRY | 1226 | 3% | 0% | 8 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 1205 | 6% | 0% | 15 |
9 | MEDICINAL CHEMISTRY RESEARCH | 910 | 2% | 0% | 5 |
10 | AAPS PHARMSCI | 664 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLORETAZINE | 971221 | 4% | 83% | 10 | Search CLORETAZINE | Search CLORETAZINE |
2 | VNP40101M | 932376 | 3% | 100% | 8 | Search VNP40101M | Search VNP40101M |
3 | NEW ANTICANCER AGENT | 407907 | 3% | 50% | 7 | Search NEW+ANTICANCER+AGENT | Search NEW+ANTICANCER+AGENT |
4 | SULFONYL HYDRAZONE | 381421 | 2% | 55% | 6 | Search SULFONYL+HYDRAZONE | Search SULFONYL+HYDRAZONE |
5 | DIPHOSPHINE DISULFIDE | 372949 | 2% | 80% | 4 | Search DIPHOSPHINE+DISULFIDE | Search DIPHOSPHINE+DISULFIDE |
6 | 1 2 BISSULFONYLHYDRAZINES | 349641 | 1% | 100% | 3 | Search 1+2+BISSULFONYLHYDRAZINES | Search 1+2+BISSULFONYLHYDRAZINES |
7 | ONRIGIN TM | 349641 | 1% | 100% | 3 | Search ONRIGIN+TM | Search ONRIGIN+TM |
8 | SELECTIVE LIQUID SOLID EXTRACTION | 349641 | 1% | 100% | 3 | Search SELECTIVE+LIQUID+SOLID+EXTRACTION | Search SELECTIVE+LIQUID+SOLID+EXTRACTION |
9 | SULFONYLHYDRAZINE PRODRUGS | 349641 | 1% | 100% | 3 | Search SULFONYLHYDRAZINE+PRODRUGS | Search SULFONYLHYDRAZINE+PRODRUGS |
10 | BISSULFONYLHYDRAZINES | 233094 | 1% | 100% | 2 | Search BISSULFONYLHYDRAZINES | Search BISSULFONYLHYDRAZINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHYAM, K , PENKETH, PG , BAUMANN, RP , FINCH, RA , ZHU, R , ZHU, YL , SARTORELLI, AC , (2015) ANTITUMOR SULFONYLHYDRAZINES: DESIGN, STRUCTURE-ACTIVITY RELATIONSHIPS, RESISTANCE MECHANISMS, AND STRATEGIES FOR IMPROVING THERAPEUTIC UTILITY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 58. ISSUE 9. P. 3639 -3671 | 46 | 35% | 5 |
2 | GUNDUZALP, AB , OZMEN, UO , CEVRIMLI, BS , MAMAS, S , CETE, S , (2014) SYNTHESIS, CHARACTERIZATION, ELECTROCHEMICAL BEHAVIOR, AND ANTIMICROBIAL ACTIVITIES OF AROMATIC/HETEROAROMATIC SULFONYLHYDRAZONE DERIVATIVES.MEDICINAL CHEMISTRY RESEARCH. VOL. 23. ISSUE 7. P. 3255 -3268 | 19 | 61% | 3 |
3 | SORBERA, LA , SERRADELL, N , (2006) VNP-40101M. DNA ALKYLATING AGENT, ONCOLYTIC..DRUGS OF THE FUTURE. VOL. 31. ISSUE 12. P. 1062-1068 | 15 | 94% | 2 |
4 | ZHU, R , BAUMANN, RP , PATRIDGE, E , PENKETH, PG , SHYAM, K , ISHIGURO, K , SARTORELLI, AC , (2013) CHLOROETHYLATING AND METHYLATING DUAL FUNCTION ANTINEOPLASTIC AGENTS DISPLAY SUPERIOR CYTOTOXICITY AGAINST REPAIR PROFICIENT TUMOR CELLS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 23. ISSUE 6. P. 1853 -1859 | 19 | 59% | 2 |
5 | PENKETH, PG , PATRIDGE, E , SHYAM, K , BAUMANN, RP , ZHU, R , ISHIGURO, K , SARTORELLI, AC , (2014) INFLUENCE OF GLUTATHIONE AND GLUTATHIONE S-TRANSFERASES ON DNA INTERSTRAND CROSS-LINK FORMATION BY 1,2-BIS(METHYLSULFONYL)-1-(2-CHLOROETHYL)HYDRAZINE, THE ACTIVE ANTICANCER MOIETY GENERATED BY LAROMUSTINE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 27. ISSUE 8. P. 1440 -1449 | 20 | 51% | 0 |
6 | ASLAN, HG , OZCAN, S , KARACAN, N , (2012) THE ANTIBACTERIAL ACTIVITY OF SOME SULFONAMIDES AND SULFONYL HYDRAZONES, AND 2D-QSAR STUDY OF A SERIES OF SULFONYL HYDRAZONES.SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY. VOL. 98. ISSUE . P. 329 -336 | 16 | 64% | 10 |
7 | GILES, F , VEY, N , DEANGELO, D , SEITER, K , STOCK, W , STUART, R , BOSKOVIC, D , PIGNEUX, A , TALLMAN, M , BRANDWEIN, J , ET AL (2009) PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF HIGH-DOSE CONTINUOUS INFUSION CYTARABINE ALONE OR WITH LAROMUSTINE (VNP40101M) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN FIRST RELAPSE.BLOOD. VOL. 114. ISSUE 19. P. 4027-4033 | 15 | 68% | 16 |
8 | SCHILLER, GJ , O'BRIEN, SM , PIGNEUX, A , DEANGELO, DJ , VEY, N , KELL, J , SOLOMON, S , STUART, RK , KARSTEN, V , CAHILL, AL , ET AL (2010) SINGLE-AGENT LAROMUSTINE, A NOVEL ALKYLATING AGENT, HAS SIGNIFICANT ACTIVITY IN OLDER PATIENTS WITH PREVIOUSLY UNTREATED POOR-RISK ACUTE MYELOID LEUKEMIA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 28. ISSUE 5. P. 815-821 | 21 | 45% | 24 |
9 | ROCKWELL, S , LIU, YF , SEOW, HA , ISHIGURO, K , BAUMANN, RP , PENKETH, PG , SHYAM, K , AKINTUJOYE, OM , GLAZER, PM , SARTORELLI, AC , (2012) PRECLINICAL EVALUATION OF LAROMUSTINE FOR USE IN COMBINATION WITH RADIATION THERAPY IN THE TREATMENT OF SOLID TUMORS.INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. VOL. 88. ISSUE 3. P. 277 -285 | 15 | 63% | 0 |
10 | PENKETH, PG , SHYAM, K , ZHU, R , BAUMANN, RP , ISHIGURO, K , SARTORELLI, AC , (2014) INFLUENCE OF PHOSPHATE AND PHOSPHOESTERS ON THE DECOMPOSITION PATHWAY OF 1,2-BIS(METHYLSULFONYL)-1-(2-CHLOROETHYHYDRAZINE (90CE), THE ACTIVE ANTICANCER MOIETY GENERATED BY LAROMUSTINE, KS119, AND KS119W.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 27. ISSUE 5. P. 818 -833 | 17 | 52% | 1 |
Classes with closest relation at Level 1 |